Genome-wide association studies (GWAS) have identified multiple chronic kidney disease (CKD)-associated single-nucleotide polymorphisms (SNPs) mainly localized to non-coding genomic regions. To understand which genes and which cell types are affected by these genetic variants, compartment-specific transcriptome, genome, and epigenome data were analyzed in an integrative manner in a recent study by Qiu et al. (Qiu et al., 2018) .
Kidney disease is a leading cause of morbidity and mortality worldwide and a major risk factor for the development of cardiovascular disease and end-stage renal disease. Little is known, however, of the extent to which genetic factors influence the development of kidney disease in the general population (Fox et al., 2004) . Different studies have shown a large degree of heritability for deficiencies in the glomerular filtration rate (GFR) (36%-75%) and for albuminuria (16%-49%). Characterizing the regulatory impact of genetic variants on complex phenotypes like chronic kidney disease (CKD) is a major challenge in understanding genotype-to-phenotype correlations. The first genome-wide association study (GWAS) in CKD, which was published in 2009 and was based on 20,000 individuals and 2,400 patients with CKD, identified UMOD, SHROOM3, and STC1 as being related to renal phenotypes (Kö ttgen et al., 2009 ). Edwards et al. have shown noncoding genetic variants associated with CKD, but the underlying genes and mechanisms remain elusive, as most of the variants are located in non-coding regions (Edwards et al., 2013) .
It has become evident that there seems to be a ''missing heritability'' pointing to the discrepancy between the high level of observed heritability of chronic diseases and the small effect on disease outcome attributable to identified variants (McCarthy et al., 2008) . In a GWAS meta-analysis by Kottgen et al., the authors showed that 16 loci account for only 1.4% of GFR variance even though the heritability of estimated GFR is thought to be about 36%-75% (Kö ttgen et al., 2010) .
To identify the biological basis of GWAS in CKD, Qiu et al. combined data from GWAS studies with an expression quantitative trait (eQTL) atlas for the glomerular and tubular compartments of human kidney samples. Subsequently, the expression of 23 out of 27 human target genes was mapped onto a mouse kidney single-cell atlas, which revealed unique cell-type-enriched expression profiles. Renal proximal tubules showed the greatest enrichment for GWAS-eQTL target genes. The authors identified Disabled-2 (DAB2), a clathrin-binding endocytic adaptor protein playing a role in cellular protein trafficking (Finkielstein and Capelluto, 2016) , as a potential CKD disease gene and showed that mice with tubularspecific reduction in Dab2 were protected from kidney fibrosis (Qiu et al., 2018) (Figure 1) . These results fit with prior findings that DAB2 is important for albumin endocytosis in the proximal tubule and that it protects cells from TGF-b-induced epithelial-to-mesenchymal transition.
The study by Qiu et al. is the first to characterize cell-type-specific eQTLs of different compartments of the human kidney. It also suggests that many diseases and conditions are perturbations of a specific cell type rather than specific organs. In line with these findings, many single-nucleotide polymorphisms (SNPs) are located in regulatory regions and are expressed in renal epithelial cells, but not in endothelial cells (Pattaro et al., 2016) . eQTLs can identify genetic variation associated with gene expression changes.
Usually this method requires a large amount of genotype-and tissue-specific gene expression data and computational methods to identify genotype-driven gene expression changes. Whole-genome sequencing (WGS), together with transcriptomes from micro-dissected glomerular and tubulo-interstitial compartments, is another approach to describe renal eQTLs and was performed in patients with nephrotic syndrome (Gillies et al., 2018) . In an earlier study, a combined CKD-GWAS and kidney eQTL analysis revealed that expression of lysosomal beta A mannosidase (MANBA) in the kidney showed significant localization with variants identified in CKD-GWASs. The functional relevance of MANBA was proven by its significantly lower expression in kidneys of subjects with risk alleles and in a zebrafish model where knockdown of manba resulted in renal tubule defects and pericardial edema (Ko et al., 2017) .
The novel study by Qiu et al. discovered many other putative causal genes for CKD development that are associated with the endolysosomal pathway and that are enriched in the proximal tubules. Alterations in the endocytic, lysosomal, and autophagy functions have been observed in CKD, supporting the relevance of the reported genes (Kimura et al., 2013) and highlighting the proximal tubule, with its high level of endocytic activity, as a site of action in CKD.
In summary, it becomes more and more evident that gene expression changes driven by genetic variation in the kidney are helpful to identify potential target genes important for CKD, with potential implications for diagnosis and
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Cell Metabolism 29, January 8, 2019 ª 2018 Elsevier Inc. 9 treatment. However, discovering genetic traits that explain the genetically determined variability of CKD is challenging given the multifactorial nature of the disease. This hurdle can only be overcome with large sample sizes and analyses of longitudinal renal phenotypes. Future studies will show if genetic variants also regulate expression of other important cellular aspects of kidney disease, such as defects in the actin cytoskeleton or mitochondrial function, increased oxidative stress, or elevated inflammatory cytokines. 
